{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:19:50Z","timestamp":1778858390418,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.yexcr.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T07:46:14Z","timestamp":1408261574000},"page":"192-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL"],"prefix":"10.1016","volume":"327","author":[{"given":"Sumit","family":"Kumar Hira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrani","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasis","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha Pratim","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2014.08.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines","volume":"117","author":"Gilboa","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2014.08.012_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.med.50.1.507","article-title":"Dendritic cell vaccines for cancer immunotherapy","volume":"50","author":"Timmerman","year":"1999","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00281-004-0167-1","article-title":"Dendritic cell-mediated T cell polarization","volume":"26","author":"de Jong","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1084\/jem.186.3.467","article-title":"Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism","volume":"186","author":"Josien","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib7","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood.V95.7.2346","article-title":"In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells","volume":"95","author":"Chapoval","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.08.012_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1189\/jlb.72.2.312","article-title":"Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro","volume":"72","author":"Manna","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib9","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.4049\/jimmunol.167.7.3565","article-title":"Tumoricidal activity of monocyte-derived dendritic cells: evidence for a caspase-8-dependent, fas-associated death domain-independent mechanism","volume":"167","author":"Vanderheyde","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib10","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.4049\/jimmunol.175.4.2408","article-title":"Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims","volume":"175","author":"Trinite","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1189\/jlb.1106674","article-title":"Natural killer dendritic cells are an intermediate of developing dendritic cells","volume":"81","author":"Chen","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.tp.0000188139.11931.98","article-title":"An antagonist mutant IL-15\/Fc promotes transplant tolerance","volume":"81","author":"Zheng","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.yexcr.2014.08.012_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.288.5466.675","article-title":"Control of homeostasis of CD8+ memory T cells by opposing cytokines","volume":"288","author":"Ku","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.08.012_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2014.08.012_bib16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1084\/jem.20070991","article-title":"Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells","volume":"204","author":"Blasius","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib17","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1084\/jem.20071351","article-title":"Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells","volume":"204","author":"Caminschi","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1465-3249(05)70786-6","article-title":"IL-15: targeting CD8+ T cells for immunotherapy","volume":"7","author":"Diab","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.yexcr.2014.08.012_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2003-12-4187","article-title":"Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance","volume":"105","author":"Kobayashi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.08.012_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib21","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.180.10.6477","article-title":"The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2","volume":"180","author":"Mignot","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib22","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1073\/pnas.0902637106","article-title":"Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2014.08.012_bib23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrc2465","article-title":"The TRAIL apoptotic pathway in cancer onset, progression and therapy","volume":"8","author":"Johnstone","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2014.08.012_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","article-title":"TRAIL signalling: decisions between life and death","volume":"39","author":"Falschlehner","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib25","first-page":"73","article-title":"Growth characteristics of free tumor cells transferred serially in the peritoneal fluid of the mouse","volume":"11","author":"Goldie","year":"1951","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib26","first-page":"139","article-title":"Differential survival of solid tumor cells after inoculation into established ascites tumors","volume":"14","author":"Klein","year":"1954","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib27","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.fct.2010.05.013","article-title":"Antitumor properties of a heteroglucan isolated from Astraeus hygrometricus on Dalton\u05f3s lymphoma bearing mouse","volume":"48","author":"Mallick","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib28","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/cncr.25869","article-title":"Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells","volume":"117","author":"Hsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2014.08.012_bib29","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-09-0536","article-title":"Cucurbitacin B induces apoptosis by inhibition of the JAK\/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells","volume":"69","author":"Thoennissen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2012.09.004","article-title":"IL-15 activated human peripheral blood dendritic cell kill allogeneic and xenogeneic endothelial cells via apoptosis","volume":"61","author":"Manna","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2014.08.012_bib31","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib32","doi-asserted-by":"crossref","first-page":"e51851","DOI":"10.1371\/journal.pone.0051851","article-title":"Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential","volume":"7","author":"Anguille","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.08.012_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.08.012_bib34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.4049\/jimmunol.1102437","article-title":"TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity","volume":"188","author":"Kalb","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/cimm.1997.1169","article-title":"Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity","volume":"180","author":"Frost","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-230X(02)85005-9","article-title":"A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance","volume":"85","author":"Ng","year":"2002","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and its death and decoy receptors","volume":"10","author":"LeBlanc","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2014.08.012_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/excr.2000.4840","article-title":"The CD95 (APO-1\/Fas) and the TRAIL (APO-2L) apoptosis systems","volume":"256","author":"Walczak","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/MCB.22.3.724-736.2002","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells","volume":"22","author":"Choi","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib40","first-page":"1314","article-title":"Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression","volume":"61","author":"Eggert","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib41","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.08.012_bib42","first-page":"7339","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac\/DIABLO release from mitochondria","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.08.012_bib43","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.4049\/jimmunol.177.4.2304","article-title":"TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation","volume":"177","author":"Huang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1096\/fj.05-5411fje","article-title":"In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells","volume":"20","author":"Chaudhry","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2014.08.012_bib45","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.174.5.2612","article-title":"Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12","volume":"174","author":"Pillarisetty","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib46","doi-asserted-by":"crossref","first-page":"18648","DOI":"10.1073\/pnas.0709198104","article-title":"Protection against simian\/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid","volume":"104","author":"Boyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2014.08.012_bib47","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.0503360102","article-title":"Survival adjustment of mature dendritic cells by IL-15","volume":"102","author":"Dubois","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2014.08.012_bib48","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1073\/pnas.1203479109","article-title":"Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2014.08.012_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4049\/jimmunol.176.1.248","article-title":"Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells","volume":"176","author":"Chaperot","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.08.012_bib50","doi-asserted-by":"crossref","first-page":"e13441","DOI":"10.1371\/journal.pone.0013441","article-title":"Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor","volume":"5","author":"Tjomsland","year":"2010","journal-title":"PloS One"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:16:23Z","timestamp":1757996183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482714003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0014482714003401"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.012","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}